Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection?
- PMID: 28165897
- DOI: 10.1200/JCO.2016.70.8156
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection?
Comment in
-
Reply to C. Buttigliero et al and B. Biswas et al.J Clin Oncol. 2017 Apr 10;35(11):1266-1267. doi: 10.1200/JCO.2016.71.7249. Epub 2017 Feb 6. J Clin Oncol. 2017. PMID: 28165905 No abstract available.
Comment on
-
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.J Clin Oncol. 2016 Sep 20;34(27):3267-75. doi: 10.1200/JCO.2016.66.7931. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325852 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
